|Presenter: Dr. Sean Boynes||Release Date: 10/25/12|
|Credits: 1 CEU||Reviewed: 2022 Expiration Date: 10/25/25|
|AGD Subject Code: 730|
|CE Supporter: Septodont|
This CE webinar will provide a comprehensive review of the pharmacology, efficacy, and safety of Oraverse. Since its FDA approval in 2008, Oraverse has been increasingly used in dental practice. There exists variation between dental providers on how it is marketed and used during the daily course of comprehensive dental care delivery. Using evidence based information including the introduction of a new study evaluating its real world use, the presentation will analyze and describe phentolamine mesylate’s role in current dental practice.
Already watched the video? Login here